Vitality Biopharma Receives $8.5 Million Common Stock Financing
23 oct. 2018 07h00 HE
|
Vitality Biopharma, Inc
Financing to support company at least into 2020 and for the initiation of multiple Phase 2 clinical trials LOS ANGELES, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...
Vitality Biopharma Sponsors Clinical Research Forum on Ending Opioid Epidemic
05 juin 2018 09h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...